Table 1 A summary of recurrent infections on day 21, day 28, day 42, and unscheduled days following treatment with artemether-lumefantrine (AL) or dihydroartemisinin-piperaquine (DP)
DRUG | Post treatment day | No of recurrent infections |
|---|---|---|
AL | D21 | 13 |
D28 | 17 | |
D42 | 12 | |
Unscheduled days after D42 | 2 | |
Total number of AL- treated recurrent infections | 44 | |
DP | D21 | 0 |
D28 | 3 | |
D42 | 14 | |
Unscheduled days after D42 | 3 | |
Total number of DP- treated recurrent infections | 20 |